Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Christgau, S; Garnero, P; Fledelius, C; Moniz, C; Ensig, M; Gineyts, E; Rosenquist, C; Qvist, P
   Collagen type IIC-telopeptide fragments as an index of cartilage degradation
   BONE
   
   S. Christgau et al., "Collagen type IIC-telopeptide fragments as an index of cartilage degradation", BONE, 29(3), 2001, pp. 209-215
2. Yamasaki, D; Enokida, M; Okano, T; Hagino, H; Teshima, R
   Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis
   BONE
   
   D. Yamasaki et al., "Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis", BONE, 28(6), 2001, pp. 634-640
3. Garnero, P; Christgau, S; Delmas, PD
   The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone
   BONE
   
   P. Garnero et al., "The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone", BONE, 28(5), 2001, pp. 461-464
4. Komine, M; Kukita, A; Kukita, T; Ogata, Y; Hotokebuchi, T; Kohashi, O
   Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappa B ligand in generation of osteoclasts in stromal cell-depletedrat bone marrow cell culture
   BONE
   
   M. Komine et al., "Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappa B ligand in generation of osteoclasts in stromal cell-depletedrat bone marrow cell culture", BONE, 28(5), 2001, pp. 474-483
5. Sun, HB; Yokota, H
   Altered mRNA level of matrix metalloproteinase-13 in MH7A synovial cells under mechanical loading and unloading
   BONE
   
   H.B. Sun e H. Yokota, "Altered mRNA level of matrix metalloproteinase-13 in MH7A synovial cells under mechanical loading and unloading", BONE, 28(4), 2001, pp. 399-403
6. Rieman, DJ; McClung, HA; Dodds, RA; Hwang, SM; Lark, MW; Holmes, S; James, IE; Drake, FH; Gowen, M
   Biosynthesis and processing of cathepsin K in cultured human osteoclasts
   BONE
   
   D.J. Rieman et al., "Biosynthesis and processing of cathepsin K in cultured human osteoclasts", BONE, 28(3), 2001, pp. 282-289
7. Sun, HB; Yokota, H
   Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cellsunder mechanical stimuli
   BONE
   
   H.B. Sun e H. Yokota, "Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cellsunder mechanical stimuli", BONE, 28(3), 2001, pp. 303-309
8. Enokida, M; Yamasaki, D; Okano, T; Hagino, H; Morio, Y; Teshima, R
   Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis
   BONE
   
   M. Enokida et al., "Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis", BONE, 28(1), 2001, pp. 87-93
9. Schultz, R; Mattila, J; Gappa, M; Verronen, P
   Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemicjuvenile arthritis (CJA)
   PEDIATRIC PULMONOLOGY
   
   R. Schultz et al., "Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemicjuvenile arthritis (CJA)", PEDIAT PULM, 32(5), 2001, pp. 397-402
10. Rosenberg, JJ; Martin, SW; Seely, JE; Kinstler, O; Gaines, GC; Fukuzuka, K; Rose, J; Kohno, T; Boyle, WJ; Nelson, A; Kieft, GL; Marshall, WS; Feige, U; Gasser, J; St Clair, J; Frazier, J; Abouhamze, A; Moldawer, LL; Edwards, CK
    Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon
    JOURNAL OF APPLIED PHYSIOLOGY
    
    J.J. Rosenberg et al., "Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon", J APP PHYSL, 91(5), 2001, pp. 2213-2223
11. Kamimura, T; Ikuta, Y
    Evaluation of grip strength with a sustained maximal isometric contractionfor 6 and 10 seconds
    JOURNAL OF REHABILITATION MEDICINE
    
    T. Kamimura e Y. Ikuta, "Evaluation of grip strength with a sustained maximal isometric contractionfor 6 and 10 seconds", J REHAB MED, 33(5), 2001, pp. 225-229
12. Rudd, PM; Colominas, C; Royle, L; Murphy, N; Hart, E; Merry, AH; Hebestreit, HF; Dwek, RA
    A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands
    PROTEOMICS
    
    P.M. Rudd et al., "A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands", PROTEOMICS, 1(2), 2001, pp. 285-294
13. McMurray, RW
    Estrogen, prolactin, and autoimmunity: actions and interactions
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    R.W. McMurray, "Estrogen, prolactin, and autoimmunity: actions and interactions", INT IMMUNO, 1(6), 2001, pp. 995-1008
14. Funk, JL
    A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    J.L. Funk, "A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases", INT IMMUNO, 1(6), 2001, pp. 1101-1121
15. Mangalam, AK; Aggarwal, A; Naik, S
    Mechanism of action of disease modifying anti-rheumatic agent, gold sodiumthiomalate (GSTM)
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    A.K. Mangalam et al., "Mechanism of action of disease modifying anti-rheumatic agent, gold sodiumthiomalate (GSTM)", INT IMMUNO, 1(6), 2001, pp. 1165-1172
16. Vorup-Jensen, T; Sorensen, ES; Jensen, UB; Schwaeble, W; Kawasaki, T; Ma, Y; Uemura, K; Wakamiya, N; Suzuki, Y; Jensen, TG; Takahashi, K; Ezekowitz, RAB; Thiel, S; Jensenius, JC
    Recombinant expression of human mannan-binding lectin
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    T. Vorup-Jensen et al., "Recombinant expression of human mannan-binding lectin", INT IMMUNO, 1(4), 2001, pp. 677-687
17. Sakuma, S; Kato, Y; Nishigaki, F; Magari, K; Miyata, S; Ohkubo, Y; Goto, T
    Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    S. Sakuma et al., "Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro", INT IMMUNO, 1(4), 2001, pp. 749-757
18. Dulos, GJ; Bagchus, WM
    Androgens indirectly accelerate thymocyte apoptosis
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    G.J. Dulos e W.M. Bagchus, "Androgens indirectly accelerate thymocyte apoptosis", INT IMMUNO, 1(2), 2001, pp. 321-328
19. Kast, RE
    Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    R.E. Kast, "Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha", INT IMMUNO, 1(12), 2001, pp. 2197-2199
20. Sukenik, S; Baradin, R; Codish, S; Neumann, L; Flusser, D; Abu-Shakra, M; Buskila, D
    Balneotherapy at the Dead Sea area for patients with psoriatic arthritis and concomitant fibromyalgia
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    S. Sukenik et al., "Balneotherapy at the Dead Sea area for patients with psoriatic arthritis and concomitant fibromyalgia", ISR MED ASS, 3(2), 2001, pp. 147-150
21. Watkins, BA; Li, Y; Lippman, HE; Seifert, MF
    Omega-3 polyunsaturated fatty acids and skeletal health
    EXPERIMENTAL BIOLOGY AND MEDICINE
    
    B.A. Watkins et al., "Omega-3 polyunsaturated fatty acids and skeletal health", EXP BIOL ME, 226(6), 2001, pp. 485-497
22. Trif, M; Guillen, C; Vaughan, DM; Telfer, JM; Brewer, JM; Roseanu, A; Brock, JH
    Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases
    EXPERIMENTAL BIOLOGY AND MEDICINE
    
    M. Trif et al., "Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases", EXP BIOL ME, 226(6), 2001, pp. 559-564
23. Adachi, JD
    Corticosteroid-induced osteoporosis
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    
    J.D. Adachi, "Corticosteroid-induced osteoporosis", INT J F W M, 46(4), 2001, pp. 190-205
24. Linn, ES; Kaunitz, AM; Schnare, S; Taylor, M
    The hormone continuum: Accrual of women's health benefits
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    
    E.S. Linn et al., "The hormone continuum: Accrual of women's health benefits", INT J F W M, 46(2), 2001, pp. 60-72
25. Rahman, MU; Poe, DS; Choi, HK
    Etanercept therapy for immune-mediated cochleovestibular disorders: Preliminary results in a pilot study
    OTOLOGY & NEUROTOLOGY
    
    M.U. Rahman et al., "Etanercept therapy for immune-mediated cochleovestibular disorders: Preliminary results in a pilot study", OTOL NEURO, 22(5), 2001, pp. 619-624
26. Feldmann, M
    Pathogenesis of arthritis: recent research progress
    NATURE IMMUNOLOGY
    
    M. Feldmann, "Pathogenesis of arthritis: recent research progress", NAT IMMUNOL, 2(9), 2001, pp. 771-773
27. Whitacre, CC
    Sex differences in autoimmune disease
    NATURE IMMUNOLOGY
    
    C.C. Whitacre, "Sex differences in autoimmune disease", NAT IMMUNOL, 2(9), 2001, pp. 777-780
28. Wang, H; Marsters, SA; Baker, T; Chan, B; Lee, WP; Fu, L; Tumas, D; Yan, MH; Dixit, VM; Ashkenazi, A; Grewal, IS
    TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice
    NATURE IMMUNOLOGY
    
    H. Wang et al., "TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice", NAT IMMUNOL, 2(7), 2001, pp. 632-637
29. Gerard, C; Rollins, BJ
    Chemokines and disease
    NATURE IMMUNOLOGY
    
    C. Gerard e B.J. Rollins, "Chemokines and disease", NAT IMMUNOL, 2(2), 2001, pp. 108-115
30. Hill, AVS
    The genomics and genetics of human infectious disease susceptibility
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS
    
    A.V.S. Hill, "The genomics and genetics of human infectious disease susceptibility", ANN REV GEN, 2, 2001, pp. 373-400
31. Davey, MP; Rosen, HR; Woody, CN; Haley, DP; Kurkinen, J; Lewinsohn, DM
    T-cell clones derived by CD3 stimulation from hepatitis C virus explanted liver tissue are not representative of dominant clones present in vivo
    LIVER TRANSPLANTATION
    
    M.P. Davey et al., "T-cell clones derived by CD3 stimulation from hepatitis C virus explanted liver tissue are not representative of dominant clones present in vivo", LIVER TRANS, 7(8), 2001, pp. 716-723
32. Keefe, FJ; Affleck, G; Lefebvre, J; Underwood, L; Caldwell, DS; Drew, J; Egert, J; Gibson, J; Pargament, K
    Giving with rheumatoid arthritis: The role of daily spirituality and dailyreligious and spiritual coping
    JOURNAL OF PAIN
    
    F.J. Keefe et al., "Giving with rheumatoid arthritis: The role of daily spirituality and dailyreligious and spiritual coping", J PAIN, 2(2), 2001, pp. 101-110
33. Hossain, MM; Margolis, DM
    Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M.M. Hossain e D.M. Margolis, "Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors", J ACQ IMM D, 28(2), 2001, pp. 199-201
34. Vorup-Jensen, T; Jensen, UB; Liu, H; Kawasaki, T; Uemura, K; Thiel, S; Dagnaes-Hansen, F; Jensen, TG
    Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver
    MOLECULAR THERAPY
    
    T. Vorup-Jensen et al., "Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver", MOL THER, 3(6), 2001, pp. 867-874
35. Yao, QP; Wang, SJ; Glorioso, JC; Evans, CH; Robbins, PD; Ghivizzani, SC; Oligino, TJ
    Gene transfer of p53 to arthritic joints stimulates synovial apoptosis andinhibits inflammation
    MOLECULAR THERAPY
    
    Q.P. Yao et al., "Gene transfer of p53 to arthritic joints stimulates synovial apoptosis andinhibits inflammation", MOL THER, 3(6), 2001, pp. 901-910
36. Misaki, Y; Ezaki, I; Ariga, T; Kawamura, N; Sakiyama, Y; Yamamoto, K
    Gene-transferred oligoclonal T cells predominantly persist in peripheral blood from an adenosine deaminase-deficient patient during gene therapy
    MOLECULAR THERAPY
    
    Y. Misaki et al., "Gene-transferred oligoclonal T cells predominantly persist in peripheral blood from an adenosine deaminase-deficient patient during gene therapy", MOL THER, 3(1), 2001, pp. 24-27
37. Barlow, J
    How to use education as an intervention in osteoarthritis
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    J. Barlow, "How to use education as an intervention in osteoarthritis", BEST PR R C, 15(4), 2001, pp. 545-558
38. Hurley, M; Walsh, N
    Physical, functional and other nonpharmacological interventions for osteoarthritis
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    M. Hurley e N. Walsh, "Physical, functional and other nonpharmacological interventions for osteoarthritis", BEST PR R C, 15(4), 2001, pp. 569-581
39. Hochberg, MC; Dougados, M
    Pharmacological therapy of osteoarthritis
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    M.C. Hochberg e M. Dougados, "Pharmacological therapy of osteoarthritis", BEST PR R C, 15(4), 2001, pp. 583-593
40. Carr, A
    Barriers to the effectiveness of any intervention in OA
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    A. Carr, "Barriers to the effectiveness of any intervention in OA", BEST PR R C, 15(4), 2001, pp. 645-656
41. Sambrook, P; Lane, NE
    Corticosteroid osteoporosis
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    P. Sambrook e N.E. Lane, "Corticosteroid osteoporosis", BEST PR R C, 15(3), 2001, pp. 401-413
42. Levine, SM; Stone, JH
    New approaches to treatment in systemic vasculitis: biological therapies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    S.M. Levine e J.H. Stone, "New approaches to treatment in systemic vasculitis: biological therapies", BEST PR R C, 15(2), 2001, pp. 315-333
43. Klareskog, L; Nordmark, B; Lindblad, S
    On the organization of an early arthritis clinic
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    L. Klareskog et al., "On the organization of an early arthritis clinic", BEST PR R C, 15(1), 2001, pp. 1-15
44. Tak, PP
    Is early rheumatoid arthritis the same disease process as late rheumatoid arthritis?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    P.P. Tak, "Is early rheumatoid arthritis the same disease process as late rheumatoid arthritis?", BEST PR R C, 15(1), 2001, pp. 17-26
45. Ollier, WER; Harrison, B; Symmons, D
    What is the natural history of rheumatoid arthritis?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    W.E.R. Ollier et al., "What is the natural history of rheumatoid arthritis?", BEST PR R C, 15(1), 2001, pp. 27-48
46. Quinn, MA; Green, MJ; Conaghan, P; Emery, P
    How do you diagnose rheumatoid arthritis early?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    M.A. Quinn et al., "How do you diagnose rheumatoid arthritis early?", BEST PR R C, 15(1), 2001, pp. 49-66
47. van Riel, PLCM; Schumacher, HR
    How does one assess early rheumatoid arthritis in daily clinical practice?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    P.L.C.M. van Riel e H.R. Schumacher, "How does one assess early rheumatoid arthritis in daily clinical practice?", BEST PR R C, 15(1), 2001, pp. 67-76
48. Griffith, J; Carr, A
    What is the impact of early rheumatoid arthritis on the individual?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    J. Griffith e A. Carr, "What is the impact of early rheumatoid arthritis on the individual?", BEST PR R C, 15(1), 2001, pp. 77-90
49. McGonagle, D; Conaghan, PG; Wakefield, R; Emery, P
    Imaging the joints in early rheumatoid arthritis
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    D. McGonagle et al., "Imaging the joints in early rheumatoid arthritis", BEST PR R C, 15(1), 2001, pp. 91-104
50. Green, MJ; Deodhar, AA
    Bone changes in early rheumatoid arthritis
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    M.J. Green e A.A. Deodhar, "Bone changes in early rheumatoid arthritis", BEST PR R C, 15(1), 2001, pp. 105-123
51. O'Dell, JR
    How is it best to treat early rheumatoid arthritis patients?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    J.R. O'Dell, "How is it best to treat early rheumatoid arthritis patients?", BEST PR R C, 15(1), 2001, pp. 125-137
52. Pincus, T; Sokka, T
    How can the risk of long-term consequences of rheumatoid arthritis be reduced?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    T. Pincus e T. Sokka, "How can the risk of long-term consequences of rheumatoid arthritis be reduced?", BEST PR R C, 15(1), 2001, pp. 139-170
53. March, L; Lapsley, H
    What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    L. March e H. Lapsley, "What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?", BEST PR R C, 15(1), 2001, pp. 171-185
54. Wallace, JL
    Pathogenesis of NSAID-induced gastroduodenal mucosal injury
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    J.L. Wallace, "Pathogenesis of NSAID-induced gastroduodenal mucosal injury", BEST PR RES, 15(5), 2001, pp. 691-703
55. Aalykke, C; Lauritsen, K
    Epidemiology of NSAID-related gastroduodenal mucosal injury
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    C. Aalykke e K. Lauritsen, "Epidemiology of NSAID-related gastroduodenal mucosal injury", BEST PR RES, 15(5), 2001, pp. 705-722
56. Smale, S; Tibble, J; Sigthorsson, G; Bjarnason, I
    Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    S. Smale et al., "Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine", BEST PR RES, 15(5), 2001, pp. 723-738
57. Bidaut-Russell, M; Gabriel, SE
    Adverse gastrointestinal effects of NSAIDs: consequences and costs
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    M. Bidaut-Russell e S.E. Gabriel, "Adverse gastrointestinal effects of NSAIDs: consequences and costs", BEST PR RES, 15(5), 2001, pp. 739-753
58. McCarthy, DM
    Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    D.M. McCarthy, "Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs", BEST PR RES, 15(5), 2001, pp. 755-773
59. Hawkey, CJ
    COX-1 and COX-2 inhibitors
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    C.J. Hawkey, "COX-1 and COX-2 inhibitors", BEST PR RES, 15(5), 2001, pp. 801-820
60. Giercksky, KE
    COX-2 inhibition and prevention of cancer
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    K.E. Giercksky, "COX-2 inhibition and prevention of cancer", BEST PR RES, 15(5), 2001, pp. 821-833
61. Chan, FKL; Sung, JJY
    Role of acid suppressants in prophylaxis of NSAID damage
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    F.K.L. Chan e J.J.Y. Sung, "Role of acid suppressants in prophylaxis of NSAID damage", BEST PR RES, 15(3), 2001, pp. 433-445
62. Tada, Y; Ho, A; Koarada, S; Morito, F; Ushiyama, O; Suzuki, N; Kikuchi, Y; Ohta, A; Mak, TW; Nagasawa, K
    Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1
    CLINICAL IMMUNOLOGY
    
    Y. Tada et al., "Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1", CLIN IMMUNO, 99(3), 2001, pp. 325-333
63. Honda, M; Mengesha, E; Albano, S; Nichols, WS; Wallace, DJ; Metzger, A; Klinenberg, JR; Linker-Israeli, M
    Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8(+)CD28(lo) T cells in patients with systemic lupus erythematosus
    CLINICAL IMMUNOLOGY
    
    M. Honda et al., "Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8(+)CD28(lo) T cells in patients with systemic lupus erythematosus", CLIN IMMUNO, 99(2), 2001, pp. 211-221
64. Salazar-Fontana, LI; Sanz, E; Merida, I; Zea, A; Sanchez-Atrio, A; Villa, L; Martinez, C; de la Hera, A; Alvarez-Mon, M
    Cell surface CD28 levels define four CD4(+) T cell subsets: Abnormal expression in rheumatoid arthritis
    CLINICAL IMMUNOLOGY
    
    L.I. Salazar-Fontana et al., "Cell surface CD28 levels define four CD4(+) T cell subsets: Abnormal expression in rheumatoid arthritis", CLIN IMMUNO, 99(2), 2001, pp. 253-265
65. Semrad, TJ; Kenny, TP; Malyj, W; Robbins, DL
    Mutational analysis of immunoglobulin germline derived V lambda 4A light chains in rheumatoid arthritis
    CLINICAL IMMUNOLOGY
    
    T.J. Semrad et al., "Mutational analysis of immunoglobulin germline derived V lambda 4A light chains in rheumatoid arthritis", CLIN IMMUNO, 99(2), 2001, pp. 276-282
66. Kenny, TP; Semrad, TJ; Malyj, W; Robbins, DL
    Mutational analysis of immunoglobulin germline derived V lambda 4B light chains in rheumatoid arthritis
    CLINICAL IMMUNOLOGY
    
    T.P. Kenny et al., "Mutational analysis of immunoglobulin germline derived V lambda 4B light chains in rheumatoid arthritis", CLIN IMMUNO, 99(2), 2001, pp. 283-290
67. Patel, DD; Koopmann, W; Imai, T; Whichard, LP; Yoshie, O; Krangel, MS
    Chemokines have diverse abilities to form solid phase gradients
    CLINICAL IMMUNOLOGY
    
    D.D. Patel et al., "Chemokines have diverse abilities to form solid phase gradients", CLIN IMMUNO, 99(1), 2001, pp. 43-52
68. Mihara, M; Kotoh, M; Nishimoto, N; Oda, Y; Kumagai, E; Takagi, N; Tsunemi, K; Ohsugi, Y; Kishimoto, T; Yoshizaki, K; Takeda, Y
    Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys
    CLINICAL IMMUNOLOGY
    
    M. Mihara et al., "Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys", CLIN IMMUNO, 98(3), 2001, pp. 319-326
69. Newman, R; Hariharan, K; Reff, M; Anderson, DR; Braslawsky, G; Santoro, D; Hanna, N; Bugelski, PJ; Brigham-Burke, M; Crysler, C; Gagnon, RC; Dal Monte, P; Doyle, ML; Hensley, PC; Reddy, MP; Sweet, RW; Truneh, A
    Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees
    CLINICAL IMMUNOLOGY
    
    R. Newman et al., "Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees", CLIN IMMUNO, 98(2), 2001, pp. 164-174
70. Martin, K; Heinzlmann, M; Borchers, R; Mack, M; Loeschke, K; Folwaczny, C
    Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease
    CLINICAL IMMUNOLOGY
    
    K. Martin et al., "Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease", CLIN IMMUNO, 98(1), 2001, pp. 18-22
71. Patel, DD; Zachariah, JP; Whichard, LP
    CXCR3 and CCR5 ligands in rheumatoid arthritis synovium
    CLINICAL IMMUNOLOGY
    
    D.D. Patel et al., "CXCR3 and CCR5 ligands in rheumatoid arthritis synovium", CLIN IMMUNO, 98(1), 2001, pp. 39-45
72. Elagib, KEE; Borretzen, M; Vatn, I; Natvig, JB; Thompson, KM
    Characterization and V-H sequences of human monoclonal anti-F(ab ')(2) autoantibodies from normals and Sjogren's syndrome patients
    CLINICAL IMMUNOLOGY
    
    K.E.E. Elagib et al., "Characterization and V-H sequences of human monoclonal anti-F(ab ')(2) autoantibodies from normals and Sjogren's syndrome patients", CLIN IMMUNO, 98(1), 2001, pp. 62-69
73. Roark, CL; Kotzin, BL
    Characterization of CD4(+) T cell autoreactivity to self-MHC in New Zealand hybrid mice
    CLINICAL IMMUNOLOGY
    
    C.L. Roark e B.L. Kotzin, "Characterization of CD4(+) T cell autoreactivity to self-MHC in New Zealand hybrid mice", CLIN IMMUNO, 98(1), 2001, pp. 95-103
74. Pelletier, M; Lavastre, V; Savoie, A; Ratthe, C; Saller, R; Hostanska, K; Girard, D
    Modulation of interleukin-15-induced human neutrophil responses by the plant lectin Viscum album agglutinin-I
    CLINICAL IMMUNOLOGY
    
    M. Pelletier et al., "Modulation of interleukin-15-induced human neutrophil responses by the plant lectin Viscum album agglutinin-I", CLIN IMMUNO, 101(2), 2001, pp. 229-236
75. Sami, N; Bhol, KC; Beutner, EH; Plunkett, RW; Leiferman, KM; Foster, CS; Ahmed, AR
    Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies
    CLINICAL IMMUNOLOGY
    
    N. Sami et al., "Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies", CLIN IMMUNO, 100(2), 2001, pp. 219-227
76. Fontenot, AP; Newman, LS; Kotzin, BL
    Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP
    CLINICAL IMMUNOLOGY
    
    A.P. Fontenot et al., "Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP", CLIN IMMUNO, 100(1), 2001, pp. 4-14
77. Buckley, CD; Pilling, D; Lord, JM; Akbar, AN; Scheel-Toellner, D; Salmon, M
    Fibroblasts regulate the switch from acute resolving to chronic persistentinflammation
    TRENDS IN IMMUNOLOGY
    
    C.D. Buckley et al., "Fibroblasts regulate the switch from acute resolving to chronic persistentinflammation", TRENDS IMMU, 22(4), 2001, pp. 199-204
78. Goldring, MB
    Anticytokine therapy for osteoarthritis
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    M.B. Goldring, "Anticytokine therapy for osteoarthritis", EXPERT OP B, 1(5), 2001, pp. 817-829
79. Freeman, BD; Buchman, TG
    Interleukin-1 receptor antagonist as therapy for inflammatory disorders
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    B.D. Freeman e T.G. Buchman, "Interleukin-1 receptor antagonist as therapy for inflammatory disorders", EXPERT OP B, 1(2), 2001, pp. 301-308
80. Haigh, RC; Blake, DR
    Understanding pain
    CLINICAL MEDICINE
    
    R.C. Haigh e D.R. Blake, "Understanding pain", CLIN MED, 1(1), 2001, pp. 44-48
81. Pantelidis, P; McGrath, DS; Southcott, AM; Black, CM; du Bois, RM
    Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific
    RESPIRATORY RESEARCH
    
    P. Pantelidis et al., "Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific", RESPIR RES, 2(6), 2001, pp. 365-372
82. Gerlag, DM; Borges, E; Tak, PP; Ellerby, HM; Bredesen, DE; Pasqualini, R; Ruoslahti, E; Firestein, GS
    Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature
    ARTHRITIS RESEARCH
    
    D.M. Gerlag et al., "Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature", ARTHRITIS R, 3(6), 2001, pp. 357-361
83. Jimenez-Balderas, FJ; Tapia-Serrano, R; Fonseca, ME; Arellano, J; Beltran, A; Yanez, P; Camargo-Coronel, A; Fraga, A
    High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction
    ARTHRITIS RESEARCH
    
    F.J. Jimenez-Balderas et al., "High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction", ARTHRITIS R, 3(6), 2001, pp. 362-367
84. Vincenti, MP; Brinckerhoff, CE
    Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1 beta
    ARTHRITIS RESEARCH
    
    M.P. Vincenti e C.E. Brinckerhoff, "Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1 beta", ARTHRITIS R, 3(6), 2001, pp. 381-388
85. Hultgren, OH; Tarkowski, A
    Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration
    ARTHRITIS RESEARCH
    
    O.H. Hultgren e A. Tarkowski, "Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration", ARTHRITIS R, 3(6), 2001, pp. 389-394
86. Cook, AD; Braine, EL; Campbell, IK; Rich, MJ; Hamilton, JA
    Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF inthe effector phase of disease
    ARTHRITIS RESEARCH
    
    A.D. Cook et al., "Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF inthe effector phase of disease", ARTHRITIS R, 3(5), 2001, pp. 293-298
87. Toyosaki-Maeda, T; Takano, H; Tomita, T; Tsuruta, Y; Maeda-Tanimura, M; Shimaoka, Y; Takahashi, T; Itoh, T; Suzuki, R; Ochi, T
    Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines
    ARTHRITIS RESEARCH
    
    T. Toyosaki-Maeda et al., "Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines", ARTHRITIS R, 3(5), 2001, pp. 306-310
88. Kinne, RW; Liehr, T; Beensen, V; Kunisch, E; Zimmermann, T; Holland, H; Pfeiffer, R; Stahl, HD; Lungershausen, W; Hein, G; Roth, A; Emmrich, F; Claussen, U; Froster, UG
    Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases
    ARTHRITIS RESEARCH
    
    R.W. Kinne et al., "Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases", ARTHRITIS R, 3(5), 2001, pp. 319-330
89. Makarov, SS
    NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction
    ARTHRITIS RESEARCH
    
    S.S. Makarov, "NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction", ARTHRITIS R, 3(4), 2001, pp. 200-206
90. Brennan, FM
    A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" byWim B van den Berg
    ARTHRITIS RESEARCH
    
    F.M. Brennan, "A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" byWim B van den Berg", ARTHRITIS R, 3(4), 2001, pp. 211-213
91. John, S; Worthington, J
    Genetic epidemiology - Approaches to the genetic analysis of rheumatoid arthritis
    ARTHRITIS RESEARCH
    
    S. John e J. Worthington, "Genetic epidemiology - Approaches to the genetic analysis of rheumatoid arthritis", ARTHRITIS R, 3(4), 2001, pp. 216-220
92. Rehman, Q; Lane, NE
    Bone loss - Therapeutic approaches for preventing bone loss in inflammatory arthritis
    ARTHRITIS RESEARCH
    
    Q. Rehman e N.E. Lane, "Bone loss - Therapeutic approaches for preventing bone loss in inflammatory arthritis", ARTHRITIS R, 3(4), 2001, pp. 221-227
93. Moreland, L; Gugliotti, R; King, K; Chase, W; Weisman, M; Greco, T; Fife, R; Korn, J; Simms, R; Tesser, J; Hillson, J; Caldwell, J; Schnitzer, T; Lyons, D; Schwertschlag, U
    Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis
    ARTHRITIS RESEARCH
    
    L. Moreland et al., "Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis", ARTHRITIS R, 3(4), 2001, pp. 247-252
94. Newkirk, MM; van Venrooij, WJ; Marshall, GS
    Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection
    ARTHRITIS RESEARCH
    
    M.M. Newkirk et al., "Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection", ARTHRITIS R, 3(4), 2001, pp. 253-258
95. Walsh, DA; Pearson, CI
    Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
    ARTHRITIS RESEARCH
    
    D.A. Walsh e C.I. Pearson, "Angiogenesis in the pathogenesis of inflammatory joint and lung diseases", ARTHRITIS R, 3(3), 2001, pp. 147-153
96. Chabaud, M; Lubberts, E; Joosten, L; van den Berg, W; Miossec, P
    IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis
    ARTHRITIS RESEARCH
    
    M. Chabaud et al., "IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis", ARTHRITIS R, 3(3), 2001, pp. 168-177
97. Scheja, A; Akesson, A; Geborek, P; Wildt, M; Wollheim, CB; Wollheim, FA; Vischer, UM
    Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
    ARTHRITIS RESEARCH
    
    A. Scheja et al., "Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)", ARTHRITIS R, 3(3), 2001, pp. 178-NIL_1
98. Dessein, PH; Joffe, BI; Stanwix, AE; Moomal, Z
    Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis
    ARTHRITIS RESEARCH
    
    P.H. Dessein et al., "Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis", ARTHRITIS R, 3(3), 2001, pp. 183-188
99. Voswinkel, J; Weisgerber, K; Pfreundschuh, M; Gause, A
    B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection
    ARTHRITIS RESEARCH
    
    J. Voswinkel et al., "B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection", ARTHRITIS R, 3(3), 2001, pp. 189-195
100. Schett, G; Tohidast-Akrad, M; Steiner, G; Smolen, J
     The stressed synovium
     ARTHRITIS RESEARCH
     
     G. Schett et al., "The stressed synovium", ARTHRITIS R, 3(2), 2001, pp. 80-86